Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16326026 | 1.00 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL10335060 | 1.00 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL1171800 | 1.00 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL18785979 | 1.00 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL13528557 | 1.00 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL20370107 | 0.84 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL6125165 | 0.84 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL461579 | 0.75 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL15973364 | 0.72 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL10900124 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11059939-B2 | Dicyclopentadiene derivatives and polymers thereof | B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2021-07-13 | — | — | US | disclosed |
| US-20190202976-A1 | DICYCLOPENTADIENE DERIVATIVES AND POLYMERS THEREOF | B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2019-07-04 | — | — | US | disclosed |
| WO-2017068588-A1 | DICYCLOPENTADIENE DERIVATIVES AND POLYMERS THEREOF | B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2017-04-27 | — | — | WO | disclosed |
| WO-2017068590-A1 | THREE-DIMENSIONAL INKJET PRINTING USING DICYCLOPENTADIENE COMPOUNDS POLYMERIZABLE BY RING-OPENING METATHESIS POLYMERIZATION | STRATASYS LTD. (IL) | 2017-04-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11059939-B2 | Dicyclopentadiene derivatives and polymers thereof | DHPS, UROD, DCPS | ALDH1A1 656/4885 |
| US-20190202976-A1 | DICYCLOPENTADIENE DERIVATIVES AND POLYMERS THEREOF | DHPS, UROD, DCPS | ALDH1A1 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.